Vebreltinib Enteric Capsules is the only First-in-class targeted drug in China that simultaneously covers three indications: MET exon 14 skipping mutation, MET amplification non-small cell lung cancer, and glioma.
Authentic
Guarantee
Fast Delivery
Privacy Vebreltinib is a prescription drug. Unauthorized personal mailing of this medication violates pharmaceutical regulatory requirements and express deliv···【Read More】
Update: 04 Feb,2026Source: Haiou HealthViews: 71
It is usually administered orally once daily. Dosage adjustments must be made strictly under the guidance of a physician.【Read More】
Update: 04 Feb,2026Source: Haiou HealthViews: 71
Vebreltinib is indicated for adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) confirmed by testing to carry MET e···【Read More】
Update: 04 Feb,2026Source: Haiou HealthViews: 79
Vebreltinib is an oral small-molecule tyrosine kinase inhibitor, primarily used for the treatment of patients with advanced or metastatic non-small ce···【Read More】
Update: 04 Feb,2026Source: Haiou HealthViews: 72
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH



